Mydecine Innovations Group’s Joshua Bartch joins the Psychedelic Spotlight podcast

← Back to all news
April 28, 2021

Mydecine Innovations Group’s Director, CEO & Co-Founder, Joshua Bartch chats with our Director of Content, Jill Ettinger, in this episode of the Psychedelic Spotlight podcast. They discuss the company's novel research protocols, its relationship with legal psilocybin growers in Jamaica, and the future for psychedelic therapy.

Click here for episode.